[Verification of the therapeutic effects of ornidazole (1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole) manufactured in Czechoslovakia in trichomoniasis in pigeons].
D000818:Animals; D001715:Bird Diseases / Q000188:drug therapy*; D010856:Columbidae; D009593:Nitroimidazoles / Q000627:therapeutic use*; D009950:Ornidazole / Q000627:therapeutic use*; D014245:Trichomonas Infections / Q000188:drug therapy / Q000662:veterinary*
D009593:Nitroimidazoles; D009950:Ornidazole
Ovĕrení terapeutického úcinku ornidazolu ceskoslovenské výroby [1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazol] pri trichomonóze holubů.